Histologic Transformation in a Patient with Lung Cancer Treated with Chemotherapy and Pembrolizumab
Journal
Journal of Thoracic Oncology
Journal Volume
12
Journal Issue
6
Pages
e75-e76
Date Issued
2017
SDGs
Other Subjects
anaplastic lymphoma kinase; cytokeratin 7; docetaxel; epidermal growth factor receptor; pembrolizumab; pemetrexed; programmed death 1 ligand 1; protein p40; thyroid transcription factor 1; vimentin; vinorelbine tartrate; immunological antineoplastic agent; monoclonal antibody; pembrolizumab; aged; ALK gene; cancer chemotherapy; cancer growth; cancer radiotherapy; case report; computer assisted tomography; drug efficacy; drug safety; dyspnea; EGFR gene; follow up; gene mutation; gene translocation; human; human tissue; Letter; lung biopsy; lymphadenopathy; male; mediastinum lymphadenopathy; multiple cycle treatment; non small cell lung cancer; pleura effusion; priority journal; protein expression; supraclavicular lymphadenopathy; treatment response; adenocarcinoma; chemically induced; lung tumor; non small cell lung cancer; pathology; prognosis; squamous cell carcinoma; Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Male; Prognosis
Publisher
Elsevier Inc
Type
letter